Maximum quantity allowed is 999
请选择数量
CAS RN: 134308-13-7 | 产品编码: T3856
Tolcapone

产品编码 | T3856 |
纯度/分析方法 | >98.0%(HPLC) |
分子式/分子量 | C__1__4H__1__1NO__5 = 273.24 |
外观与形状(20°C) | 固体 |
储存温度 | 冷藏 (0-10°C) |
应避免的情况 | 加热 |
包装和容器 | 200MG-Glass Bottle with Plastic Insert (查看图片), 50MG-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 134308-13-7 |
Reaxys-RN | 8151577 |
PubChem物质ID | 468592985 |
Merck Index (14) | 9508 |
MDL编号 | MFCD00866569 |
技术规格
Appearance | White to Yellow to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 142.0 to 146.0 °C |
物性(参考值)
熔点 | 145 °C |
GHS
相关法规
RTECS# | PC4952500 |
运输信息
HS编码* | 2914.79-000 |
应用
Tolcapone: A Selective and Reversible Inhibitor of Catechol-O-methyltransferase (COMT)
Tolcapone is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT) which is one of several enzymes that degrade catecholamines (such as L-DOPA [D0600], dopamine [A0305], L-epinephrine [A0173], and norepinephrine [A0906]). COMT catalyzes the transfer of the methyl group of S-adenosyl-L-methionine to the phenolic group of substrates that contain a catechol structure including catecholamines. Tolcapone crosses the blood-brain barrier and can inhibit both peripheral and central COMT activity. Therefore, it has been suggested that tolcapone prolong the biological half-life of L-DOPA and the therapeutic effect of L-DOPA for Parkinson's disease patients. (The product is for research purpose only.)
References
- Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-DOPA and dopamine in rats
- Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex
- Catechol-O-methyltransferase and its inhibitors in Parkinson's disease (a review)
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。